Rheumatology Association of Iowa 6th Annual Meeting
Healthcare professionals who work in Rheumatology.
Effective management in ANCA-associated vasculitis (AAV), specifically Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) include not only the use of evidence-based treatments but also rigorous application of monitoring and preventive strategies to reduce the risk of infection and medication-specific toxicities. Rheumatologists need to be aware of these strategies to provide their patients with the best outcomes.
For the two main forms of Large-vessel vasculitis (LVV), Giant Cell Arteritis (GCA) and Takayasu Arteritis (TAK), non-medical management should be considered for disease that is threatening a critical organ or for significant symptoms impacting quality of life.
Today’s challenging health care environment is affecting the way physicians manage their practices, interfering with access to care and forcing them to make difficult decisions. Physicians seek to continue to provide quality care while contending with reduced Medicare reimbursement rates, medical claims, process errors and inefficiency, and legislative and regulatory changes. Rheumatologists need to be aware of emerging trends in practice management, payer reform, and administrative simplification of impact to the success of their practices and quality of patient care.
- Recognize federal efforts to improve value in healthcare delivery and payment through programs established under the Medicare Access and CHIP Reauthorization Act (MACRA)
- Distinguish and contrast pathways for Rheumatologists to be reimbursed under the Quality Payment Program (i.e., the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs).
- Evaluate the potential impact of MACRA on Rheumatology practices and estimate the significance of engagement in current and future value-driven delivery and payment models.
- Identify opportunities for state and national advocacy, legislative action and our need for representation at the state national level.
- Identify the clinical features of ANCA-associated vasculitis.
- Describe the approach to diagnosis for ANCA-associated vasculitis.
- List the treatment options for ANCA-associated vasculitis.
- Describe the diseases that can be associated with large vessel vasculitis.
- Identify the clinical features associated with giant cell arteritis and Takayasu arteritis.
- Discuss the treatment approaches to giant cell arteritis and Takayasu arteritis.
All sessions will be located in the Amphitheater unless otherwise noted. Speakers and times are subject to change.
|FRIDAY, FEBRUARY 21, 2020|
Welcome and Opening Remarks
Emily L. Graham, RHIA, CCS-P
|SATURDAY, FEBRUARY 22, 2020|
|9 am||Welcome and Opening Remarks|
SSc Lung Disease Screening: Time for a Paradigm?
Jerry A. Molitor, MD, PhD
Forecasting Rheumatoid Arthritis: Mostly Cloudy with A Chance of Prevention
Jerry A. Molitor, MD, PhD
RAI Annual Business Meeting
|2 pm||Advocacy Panel|
Emily L. Graham, RHIA, CCS-P
Understanding the Rationale for Newer IL-17-Targeted Arthritis Psoriatic Arthritis Therapies: Essentials for Clinicians
* This session is accredited separately through the joint providership of the National Psoriasis Foundation (NPF) and RockPointe; all CME information will be available on-site.
Questions and Accommodations Requests
RAI Executive Office
Phone: (847) 517-7225
Hotel Deadline:January 31, 2020
The Hotel Kirkwood Center is offering RAI attendees a special conference rate of $135.00, plus applicable state and local taxes. This discounted group rate applies until the reservation deadline of January 31, 2020, or until all so-designated rooms are booked, whichever occurs first. RAI encourages you to make your reservations early, as after this date reservations will be accepted based on hotel availability and/or higher rates may apply.
Attendees are responsible for making their reservations by calling the hotel at (877) 751-5111. Please be sure to mention the RAI 6th Annual Meeting to receive these discounted rates.
Hotel Deposit and Cancellation Policy: In order to avoid penalty, cancellation must be made by 4:00 p.m. (CST) day of arrival.
Airport Information: The Eastern Iowa Airport (CID) is approximately four miles from The Hotel at Kirkwood Center or six minutes by car.
Taxi Cab Services: Several taxi companies operate at the Eastern Iowa Airport and are located outside of the baggage claim area. Taxi rates for a one-way transfer to the hotel cost approximately $15.00.
Rental Car Information: Avis® Rent-A-Car is the official rental car company for the RAI meeting. For reservations, please call (800) 331-1600, and use the code “J901055” to receive the discounted rates.
Parking: The Hotel at Kirkwood Center offers complimentary parking for registered guests and valet parking for $4.00 per day plus tax for day guests. Please note that rates are subject to change.
Emily L. Graham, RHIA, CCS-P
Ms. Graham is Vice President of Regulatory Affairs. Before her move to Hart Health Strategies Inc., Ms. Graham served as the Assistant Dean and Program Director for the Health Information Management (HIM) and Clinical Data Coding (CDC) Programs at Northern Virginia Community College's (NVCC) Medical Education Campus (MEC). Ms. Graham continues to serve as an adjunct faculty member for the traditional HIM/CDC programs, as well as the Office of the National Coordinator's (ONC) Community College Consortium Health IT Workforce Development Program.
Prior to her time in academia, Ms. Graham served as the Associate Director of Regulatory Affairs for the American Society of Cataract and Refractive Surgery (ASCRS), where she focused on a variety of regulatory issues, including Medicare physician reimbursement, Medicare's quality improvement initiatives and advancements in health information technology. In that role she had regular dealings with representatives of the Department of Health and Human Services, to include the CMS, the ONC, and the FDA. She also served as Chair of the Quality and Health Information Technology and Regulatory Committee's for the Alliance of Specialty Medicine and as a staff liaison to the AMA's Current Procedural Terminology (CPT) Editorial Panel and Relative Value System Update Committee (RUC), the NQF, SQA, and AQA Alliance.
Ms. Graham previously held a position at the American Academy of Otolaryngology - Head Neck Surgery as a Practice Management Coordinator, where she focused on coding and reimbursement issues. She has also held positions in an acute care hospital billing office and in a physician practice.
Ms. Graham is a Past President of the District of Columbia Health Information Management Association (DCHIMA). Ms. Graham obtained her Bachelor of Science Degree in HIM from Stephens College.
WJWeiser & Associates, Inc.
Jerry A. Molitor, MD, PhD
Dr. Jerry A. Molitor is an Associate Professor of Medicine in the Division of Rheumatic and Autoimmune Diseases at the University of Minnesota Medical School. Dr. Molitor earned his PhD in Microbiology and Immunology at Duke University, where he helped develop evidence of a family of NF-kappa B nuclear transcription factors in T lymphocytes. He completed his MD at the University Of Iowa College Of Medicine. Dr. Molitor completed his Internal Medicine Internship and Residency, as well as a Rheumatology Fellowship, at the University of Washington. Dr. Molitor conducted numerous clinical and translational research projects through the Benaroya Research Institute at Virginia Mason, where he was Director of the Arthritis Clinical Research Unit from 2001-2007, and Associate Director of Clinical Research from 2004-2007. He joined the University of Minnesota in 2007, where he heads the multidisciplinary Scleroderma clinic. He has participated in the Scleroderma GWAS, and in multiples studies of Systemic Sclerosis biomarkers and natural history, as well as in various aspects of drug development. Dr. Molitor has clinical research interests in Early Rheumatoid Arthritis and Systemic Sclerosis pathogenesis and disease prevention, and has been a consultant or investigator in multiple trials of candidate therapies for these conditions. His translational research focuses on understanding the interplay between impaired immune responses to infections and associated autoimmunity. He leads current studies examining this phenomenon in individuals with periodontal disease and the development of Rheumatoid Arthritis–associated autoantibodies.
Director, External Affairs, Iowa Medical Society
Relevant to the content of this educational activity, the following individuals have no conflict of interests with commercial interests to disclose.
- Bogdan Cherascu, MD, MS, Activity Director and Planning Committee Member
- Emily L. Graham, RHIA, CCS-P, Speaker
- Lorene Harder, Activity Coordinator and Planning Committee Member
- Brian Henderson, Panelist
- Dennis Tibben, Panelist
Relevant to the content of this educational activity, the following individuals a conflict of interest with commercial interests to disclose.
- Jerry A. Molitor, MD, PhD, Speaker
|Company||Role with Commercial Interest||Nature of Relationship|
|Eicos Sciences, Inc.||Consultant||Clinical Trial Steering Committee|
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 4.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Rheumatology Association of Iowa. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 4.0 continuing education contact hour(s). No partial credit awarded.
- Other: This live activity is designated for 4.0 AMA PRA Category 1 Credit(s)TM.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 4.00 AOA Category 2A
- 4.00 AMA PRA Category 1 Credits™
- 4.00 IBON
- 4.00 CE Contact Hour(s)
- Complimentary: Member - Physician
- $50.00: Nonmember - Physician
- Complimentary: Member - Non-physician
- $25.00: Nonmember - Non-physician
- Complimentary: Student, Fellow, Resident
Registration Cancellation and Refund Policy: Registration refund requests must be submitted in writing to the RAI Executive Office no later than 1/31/2020. All refund requests will be subject to a $5.00 processing fee. No refunds will be made after 1/31/2020.